You know the big hitters in surgical robotics. Here are some of the companies you may not know about, but you should keep an eye on them. Last month, MassDevice compiled a list of 16 surgical robotics companies you need to know. That list included the usual suspects, like Intuitive, Medtronic, Johnson & Johnson and more. […]
robot-assisted
Virtuoso Surgical announces $20M offering for endoscopic surgical robot
Virtuoso Surgical announced today that its $20 million stock offering became effective after review by the U.S. SEC. Nashville, Tennessee–based Virtuoso develops a surgical robot system for minimally invasive endoscopic surgery. Its founders developed its patented technology at Johns Hopkins University and Vanderbilt University. In addition, the National Science Foundation and the National Institutes of […]
FDA clears eCential Robotics’ spine surgery robot
French robotic spine surgery tech company eCential Robotics announced today that it has received FDA clearance for its 3D imaging, navigation and robotics guidance system. With the help of recent partnerships with U.S. implant companies, Gières, France–based eCential Robotics plans to start selling its surgical robotics system in North America. The company has already sold […]
Titan Medical to start manufacturing Enos systems later this year
Titan Medical (Nasdaq: TMDI; TSX: TMD) expects manufactured units of the Enos robotic-assisted surgery system will be available later this year. The goal is to commercially launch Enos in early 2025 after securing a De Novo market authorization from the FDA, the Toronto-based robotic surgery company said during its second-quarter earnings report today. Titan Medical […]
Stereotaxis stock down amid cloudy outlook
Stereotaxis (NYSE: STXS) today reported second-quarter revenue that missed Wall Street projections, with the surgical robotics company unable to say how quickly revenue will pick up. Investors reacted by sending STXS shares down more than 18% to $2.10 apiece by late afternoon trading today. The St. Louis–based company lost $5.1 million, or 7¢ per share, […]
Vicarious Surgical completes Beta 2 system design
Vicarious Surgical (NYSE:RBOT) continues to progress in the development of its Beta 2 robotic surgery platform, though supply chain disruption poses risks for the company’s timeline. That appeared to be the big message out of the Waltham, Massachusetts–based surgical robotics company’s Q2 earnings report yesterday evening. Vicarious Surgical’s technology uses proprietary human-like surgical robots combined […]
Asensus Surgical says procedures up by more than a third in Q2
Asensus Surgical (NYSE American: ASXC) today announced mixed Q2 results that also included 34% procedures growth year-over-year. The Research Triangle Park, North Carolina–based surgical robotics and digital surgery company lost $19.6 million, or 8¢ per share, off $994,000 in revenue for the quarter ended June 20, 2022 — versus a loss of $13.2 million, or […]
Does Asensus Surgical have a Russia problem?
Add the Russia-Ukraine war to the potential challenges facing Asensus Surgical (NYSE American: ASXC) as it seeks to innovate in the surgical robotics space. Research Triangle Park, North Carolina–based Asensus today announced the sale of one of its Senhance surgical systems, an important development given that its 2021 annual report lists a total of two […]
Medical Microinstruments raises $75M for robotic microsurgery
Robotic microsurgery company Medical Microinstruments announced today that it raised $75 million in a Series B financing round. Pisa, Italy–based Medical Microinstruments plans to use proceeds from the financing round, along with its planned U.S. presence, to move into its next stage of growth through expanded indications and ongoing commercialization efforts for its Symani microsurgery […]
Former Mazor VP accused of insider trading around Medtronic acquisition
A former Mazor Robotics VP is among three businessmen facing federal insider trading charges and an SEC lawsuit over stock trades leading up to Medtronic’s $1.6 billion acquisition announcement in 2018. Ron Tavlin was Mazor’s VP of business development from 2017 to 2019. Before that, he’d been a paid consultant for Medtronic. The U.S. Attorney’s […]
Nasdaq grants Titan Medical 180-day extension to regain compliance
Titan Medical (Nasdaq:TMDI) announced today that it received an additional 180 days to regain compliance with the Nasdaq market. According to a news release, the Listing Qualifications Staff of The Nasdaq Stock Market notified the company that it received 180 extra calendar days — running through Dec. 26, 2022 — to evidence compliance with the […]
